Table 3

Base-case results for different pretest probabilities. Dominated strategies not shown, except when significant uncertainty regarding dominance on sensitivity analysis

Pretest probabilityStrategyAvg cost per patient (I$)C-E
(I$/diag)
ICER
(I$/diag)
Accuracy (%)FN
(%)
Deaths (%)Invasive CA (%)Negative invasive CA (%)
Low2 (Ex-ECG→CTA → CA)125135-937.40.009185
1 (Ex-ECG → ECHO → CA)141153-927.60.0122512
9 (CTA → CA)1972021420*982.40.0072912
8 (C-MRI → CA)31532247 800†982.10.0083719
Moderate2 (Ex-ECG → CTA → CA)188231-8118.50.013353
4 (Ex-ECG → CA)205240415‡8614.30.0175823
9 (CTA → CA)269286750§945.90.011517
6 (ECHO → CA)286305-946.40.0176117
8 (C-MRI → CA)38540717 800†955.20.0125712
High4 (Ex-ECG → CA)222278-8020.10.0186314
9 (CTA → CA)317345790§928.20.014664
6 (ECHO → CA)320351-918.90.0197110
10 (CA → ECHO)373381273†981.70.0210030
  • *ICER vs strategy 1.

  • †ICER vs strategy 9.

  • ‡ICER vs strategy 2.

  • §ICER vs strategy 4.

  • Avg, average; CA, invasive coronary angiography; C-E, cost-effectiveness; C-MRI, cardiac MRI;  CTA, CT coronary angiogram; ECHO, stress echocardiogram; Ex-ECG, exercise ECG; FN, false-negative; ICER, incremental cost-effectiveness ratio. ;